Infectious Disease Featured News Articles

Features

hepatitis C

Decreasing Hepatitis C Infection Rates — Considerations for a Vaccine

Infection with the hepatitis C virus (HCV) is a significant public health problem throughout the world and constitutes a major global cause of morbidity and mortality. Recent estimates indicate that the global rate of HCV seroprevalence increased to 2.8% in the last decade, which corresponds to >185 million cases of HCV worldwide.1 To reduce the…
Lower doses and shorter treatment regimens have the potential to reduce both physical and financial

Infection Control and Prevention Strategies for Patients With Cancer

Infection control and prevention (ICP) strategies represent an integral part of care for patients with oncologic diseases. Although the relevant guidelines often include established practices such as hand hygiene, barrier isolation, control of air quality, prevention of device-related infections, and prophylactic antifungal and antibiotic use, there are currently no consensus recommendations pertaining to ICP strategies…
Liver cancer

Oncovirus and Aggressive Malignancy

Researchers found data that showed infection-associated cancers are attributable to hepatitis B virus, hepatitis C virus, human papillomaviruses, and the bacterium Helicobacter pylori. Approximately half of all cancers in the United States are preventable. Also, the CDC suggests that identifying organ donors who are at high risk for oncoviruses and providing post-treatment to donor recipients for infection will mitigate oncovirus risks.